FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

V Huter

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
V Huter; Andreas Hensel; E Brand; Werner Lubitz
Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine.
Andreas Hensel; V Huter; A Katinger; P Raza; C Strnistschie; Uwe Roesler; E Brand; Werner Lubitz
Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
V Huter; Michael Szostak; J Gampfer; S Prethaler; G Wanner; Franz Gabor; Werner Lubitz
Bacterial ghosts as drug carrier and targeting vehicles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of V Huter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: V Huter; Andreas Hensel; E Brand; Werner Lubitz
Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine.
Journal of biotechnology 2000;83(1-2):161-72.
2000: Andreas Hensel; V Huter; A Katinger; P Raza; C Strnistschie; Uwe Roesler; E Brand; Werner Lubitz
Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
Vaccine 2000;18(26):2945-55.
1999: V Huter; Michael Szostak; J Gampfer; S Prethaler; G Wanner; Franz Gabor; Werner Lubitz
Bacterial ghosts as drug carrier and targeting vehicles.
Journal of controlled release : official journal of the Controlled Release Society 1999;61(1-2):51-63.
1999: Werner Lubitz; Angela Witte; Francis O Eko; M Kamal; Wolfgang Jechlinger; E Brand; J Marchart; Wolfgang Haidinger; V Huter; Diana Felnerova; N Stralis-Alves; S Lechleitner; Helen Melzer; Michael Szostak; Stephanie Resch; HJ Mader; B Kuen; Burkhard Mayr; Peter Mayrhofer; R Geretschläger; Alexander G Haslberger; Andreas Hensel
Extended recombinant bacterial ghost system.
Journal of biotechnology 1999;73(2-3):261-73.
1999: A Katinger; Werner Lubitz; Michael Szostak; M Stadler; R Klein; Alexander Indra; V Huter; Andreas Hensel
Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses.
Journal of biotechnology 1999;73(2-3):251-60.
1999: Francis O Eko; Angela Witte; V Huter; B Kuen; S Fürst-Ladani; Alexander G Haslberger; A Katinger; Andreas Hensel; Michael Szostak; Stephanie Resch; HJ Mader; P Raza; E Brand; J Marchart; Wolfgang Jechlinger; Wolfgang Haidinger; Werner Lubitz
New strategies for combination vaccines based on the extended recombinant bacterial ghost system.
Vaccine 1999;17(13-14):1643-9.
1997: Michael Szostak; HJ Mader; Michael Truppe; M Kamal; Francis O Eko; V Huter; J Marchart; Wolfgang Jechlinger; Wolfgang Haidinger; E Brand; Ewald denner; Stephanie Resch; E Dehlin; A Katinger; B Kuen; Alexander G Haslberger; Andreas Hensel; Werner Lubitz
Bacterial ghosts as multifunctional vaccine particles.
Behring Institute Mitteilungen 1997;(98):191-6.